See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100412_2017_Array_Biopharma_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001100412, Array Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 155,301,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,680,000 |
| 3 | remainder_Assets | 6,919,000 |
| 4 | LiabilitiesCurrent | 52,434,000 |
| 5 | LiabilitiesNoncurrent | 154,398,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 24,235,996 |
| 8 | SellingGeneralAndAdministrativeExpense | 37,099,578 |
| 9 | ResearchAndDevelopmentExpense | 159,937,935 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 169,868,551 |
| 12 | remainder_NetIncome | 87,405,076 |
| 13 | remainder_ComprehensiveNetIncome | 3,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 168,900,000 |
| 1 | Liabilities | 206,832,000 |
| 2 | Expenses | 221,273,509 |
| 3 | Revenues | 169,868,551 |
| 4 | StockholdersEquity | -37,932,000 |
| 5 | NetIncome | 36,000,118 |
| 6 | ComprehensiveNetIncome | 36,001,618 |
| 7 | BaseVar | 427,141,068 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.249 |
| 9 | EconomicCapitalRatio | 1.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
